Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3626000 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL27656728 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3625436 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL37594 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL14012811 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL17359326 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3627595 | 1.00 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7483482 | 0.97 | CYP2D6 (0.47) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3639921 | 0.89 | — | — | |
| SCHEMBL27549539 | 0.89 | TSHR (0.54) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9809717-B2 | Antimicrobial-coated medical articles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-11-07 | — | — | US | disclosed |
| EP-2576471-B1 | ANTIMICROBIAL COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2017-10-25 | — | — | EP | disclosed |
| EP-2576472-B1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-03-23 | — | — | EP | disclosed |
| US-20150175812-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2015-06-25 | — | — | US | disclosed |
| US-20150024019-A1 | ANTIMICROBIAL-COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2015-01-22 | — | — | US | disclosed |
| EP-2576471-A2 | ANTIMICROBIAL COATED MEDICAL ARTICLES | 3M Innovative Properties Company (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2576472-A2 | ANTIMICROBIAL COATINGS | 3M Innovative Properties Company (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-01-19 | — | — | US | disclosed |
| WO-2011150001-A2 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011150103-A2 | ANTIMICROBIAL–COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| US-7789934-B2 | Combination of an N-alkyl- or N,N-dialkylpolyhydroxyalkanamide and a metal soap, an alkylenebisfatty amide, or an N-alkylalkanamide; improves both flowability and lubricity, regardless of a presence or absence of a complicated pretreatment step. | KABUSHIKI KAISHA KOBE SEIKO SHO (JP) | 2010-09-07 | — | — | US | disclosed |
| CN-100549146-C | Lubricant for powder metallurgy, mixed powder for powder metallurgy, and method for producing sintered body | KOBE STEEL LTD (JP) | 2009-10-14 | — | — | CN | disclosed |
| US-20070154340-A1 | Lubricant for powder metallurgy, powdery mixture for powder metallurgy, and process for producing sinter | KABUSHIKI KAISHA KOBE SEIKO SHO (JP) | 2007-07-05 | — | — | US | disclosed |
| CN-1910266-A | Lubricant for powder metallurgy, powdery mixture for powder metallurgy, and process for producing sinter | KOBE STEEL LTD (JP) | 2007-02-07 | — | — | CN | disclosed |
| CN-1125394-A | Novel therapeutic drug delivery system | IMARX PHARMACEUTICAL CORP (US) | 1996-06-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | ARG1, CAPG, CLSPN | DNM1 901/4885TSHR 4723/4885MEN1 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.